Literature DB >> 27742547

Distribution of particles, small molecules and polymeric formulation excipients in the suprachoroidal space after microneedle injection.

Bryce Chiang1, Nitin Venugopal2, Henry F Edelhauser3, Mark R Prausnitz4.   

Abstract

The purpose of this work was to determine the effect of injection volume, formulation composition, and time on circumferential spread of particles, small molecules, and polymeric formulation excipients in the suprachoroidal space (SCS) after microneedle injection into New Zealand White rabbit eyes ex vivo and in vivo. Microneedle injections of 25-150 μL Hank's Balanced Salt Solution (HBSS) containing 0.2 μm red-fluorescent particles and a model small molecule (fluorescein) were performed in rabbit eyes ex vivo, and visualized via flat mount. Particles with diameters of 0.02-2 μm were co-injected into SCS in vivo with fluorescein or a polymeric formulation excipient: fluorescein isothiocyanate (FITC)-labeled Discovisc or FITC-labeled carboxymethyl cellulose (CMC). Fluorescent fundus images were acquired over time to determine area of particle, fluorescein, and polymeric formulation excipient spread, as well as their co-localization. We found that fluorescein covered a significantly larger area than co-injected particles when suspended in HBSS, and that this difference was present from 3 min post-injection onwards. We further showed that there was no difference in initial area covered by FITC-Discovisc and particles; the transport time (i.e., the time until the FITC-Discovisc and particle area began dissociating) was 2 d. There was also no difference in initial area covered by FITC-CMC and particles; the transport time in FITC-CMC was 4 d. We also found that particle size (20 nm-2 μm) had no effect on spreading area when delivered in HBSS or Discovisc. We conclude that (i) the area of particle spread in SCS during injection generally increased with increasing injection volume, was unaffected by particle size, and was significantly less than the area of fluorescein spread, (ii) particles suspended in low-viscosity HBSS formulation were entrapped in the SCS after injection, whereas fluorescein was not and (iii) particles co-injected with viscous polymeric formulation excipients co-localized near the site of injection in the SCS, continued to co-localize while spreading over larger areas for 2-4 days, and then no longer co-localized as the polymeric formulation excipients were cleared within 1-3 weeks and the particles remained largely in place. These data suggest that particles encounter greater barriers to flow in SCS compared to molecules and that co-localization of particles and polymeric formulation excipients allows spreading over larger areas of the SCS until the particles and excipients dissociate.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Microneedle injection; Suprachoroidal space; Targeted ocular drug delivery; Tissue distribution in eye

Mesh:

Substances:

Year:  2016        PMID: 27742547      PMCID: PMC5121071          DOI: 10.1016/j.exer.2016.10.011

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  25 in total

1.  Particle-stabilized emulsion droplets for gravity-mediated targeting in the posterior segment of the eye.

Authors:  Yoo C Kim; Henry F Edelhauser; Mark R Prausnitz
Journal:  Adv Healthc Mater       Date:  2014-03-20       Impact factor: 9.933

2.  Effect of needle type and injection technique on pain level and vitreal reflux in intravitreal injection.

Authors:  Eduardo B Rodrigues; Astor Grumann; Fernando M Penha; Helio Shiroma; Eglas Rossi; Carsten H Meyer; Vinicius Stefano; Maurício Maia; Octaviano Magalhaes; Michel E Farah
Journal:  J Ocul Pharmacol Ther       Date:  2011-02-12       Impact factor: 2.671

3.  Statistical tests for measures of colocalization in biological microscopy.

Authors:  John H McDonald; Kenneth W Dunn
Journal:  J Microsc       Date:  2013-10-10       Impact factor: 1.758

4.  Suprachoroidal drug delivery to the back of the eye using hollow microneedles.

Authors:  Samirkumar R Patel; Angela S P Lin; Henry F Edelhauser; Mark R Prausnitz
Journal:  Pharm Res       Date:  2010-09-21       Impact factor: 4.200

5.  Transplantation of human bone marrow mesenchymal stem cells as a thin subretinal layer ameliorates retinal degeneration in a rat model of retinal dystrophy.

Authors:  Adi Tzameret; Ifat Sher; Michael Belkin; Avraham J Treves; Amilia Meir; Arnon Nagler; Hani Levkovitch-Verbin; Iris Barshack; Mordechai Rosner; Ygal Rotenstreich
Journal:  Exp Eye Res       Date:  2013-11-13       Impact factor: 3.467

6.  Coated microneedles for drug delivery to the eye.

Authors:  Jason Jiang; Harvinder S Gill; Deepta Ghate; Bernard E McCarey; Samir R Patel; Henry F Edelhauser; Mark R Prausnitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

7.  Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma.

Authors:  B Chiang; Y C Kim; A C Doty; H E Grossniklaus; S P Schwendeman; M R Prausnitz
Journal:  J Control Release       Date:  2016-02-28       Impact factor: 9.776

8.  Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles.

Authors:  Yoo C Kim; Henry F Edelhauser; Mark R Prausnitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-11       Impact factor: 4.799

9.  Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab.

Authors:  Puneet Tyagi; Matthew Barros; Jeffrey W Stansbury; Uday B Kompella
Journal:  Mol Pharm       Date:  2013-07-08       Impact factor: 4.939

10.  Ab-externo AAV-mediated gene delivery to the suprachoroidal space using a 250 micron flexible microcatheter.

Authors:  Marc C Peden; Jeff Min; Craig Meyers; Zachary Lukowski; Qiuhong Li; Sanford L Boye; Monica Levine; William W Hauswirth; Ramakrishna Ratnakaram; William Dawson; Wesley C Smith; Mark B Sherwood
Journal:  PLoS One       Date:  2011-02-11       Impact factor: 3.240

View more
  13 in total

1.  Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle.

Authors:  Jae Hwan Jung; Bryce Chiang; Hans E Grossniklaus; Mark R Prausnitz
Journal:  J Control Release       Date:  2018-03-02       Impact factor: 9.776

Review 2.  The suprachoroidal space as a route of administration to the posterior segment of the eye.

Authors:  Bryce Chiang; Jae Hwan Jung; Mark R Prausnitz
Journal:  Adv Drug Deliv Rev       Date:  2018-03-12       Impact factor: 15.470

3.  Collagenase injection into the suprachoroidal space of the eye to expand drug delivery coverage and increase posterior drug targeting.

Authors:  Jae Hwan Jung; Sanghyun Park; J Jeremy Chae; Mark R Prausnitz
Journal:  Exp Eye Res       Date:  2019-10-01       Impact factor: 3.467

4.  Choroidal Changes After Suprachoroidal Injection of Triamcinolone Acetonide in Eyes With Macular Edema Secondary to Retinal Vein Occlusion.

Authors:  Alex S Willoughby; Vivian S Vuong; David Cunefare; Sina Farsiu; Glenn Noronha; Ronald P Danis; Glenn Yiu
Journal:  Am J Ophthalmol       Date:  2017-12-02       Impact factor: 5.258

Review 5.  Non-transdermal microneedles for advanced drug delivery.

Authors:  KangJu Lee; Marcus J Goudie; Peyton Tebon; Wujin Sun; Zhimin Luo; Junmin Lee; Shiming Zhang; Kirsten Fetah; Han-Jun Kim; Yumeng Xue; Mohammad Ali Darabi; Samad Ahadian; Einollah Sarikhani; WonHyoung Ryu; Zhen Gu; Paul S Weiss; Mehmet R Dokmeci; Nureddin Ashammakhi; Ali Khademhosseini
Journal:  Adv Drug Deliv Rev       Date:  2019-12-16       Impact factor: 15.470

6.  Clearance Kinetics and Clearance Routes of Molecules From the Suprachoroidal Space After Microneedle Injection.

Authors:  Bryce Chiang; Ke Wang; C Ross Ethier; Mark R Prausnitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

7.  Thickness and Closure Kinetics of the Suprachoroidal Space Following Microneedle Injection of Liquid Formulations.

Authors:  Bryce Chiang; Nitin Venugopal; Hans E Grossniklaus; Jae Hwan Jung; Henry F Edelhauser; Mark R Prausnitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

8.  Targeted Drug Delivery in the Suprachoroidal Space by Swollen Hydrogel Pushing.

Authors:  Jae Hwan Jung; Patcharin Desit; Mark R Prausnitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-04-01       Impact factor: 4.799

Review 9.  Polysaccharides in Ocular Drug Delivery.

Authors:  Natallia Dubashynskaya; Daria Poshina; Sergei Raik; Arto Urtti; Yury A Skorik
Journal:  Pharmaceutics       Date:  2019-12-24       Impact factor: 6.321

10.  Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates.

Authors:  Glenn Yiu; Sook Hyun Chung; Iris N Mollhoff; Uyen Tu Nguyen; Sara M Thomasy; Jesse Yoo; Donna Taraborelli; Glenn Noronha
Journal:  Mol Ther Methods Clin Dev       Date:  2020-01-21       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.